Resistance to β-lactams in Streptococcus pneumoniae
Revista Argentina de Microbiología, ISSN: 0325-7541, Vol: 53, Issue: 3, Page: 266-271
2021
- 10Citations
- 90Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes10
- 10
- Captures90
- Readers90
- 87
Article Description
Streptococcus pneumoniae is an important causal agent of pneumonia, meningitis, sepsis, bacteremia, and otitis media. Penicillin resistance rates in S. pneumoniae have remained stable in Argentina in the last years. In the late ‘90s more isolates with MIC of penicillin ≥2 μg/ml were observed; however, their frequency has decreased in recent years. The phenotypic expression of penicillin resistance is due to a modification in penicillin-binding proteins associated with a mosaic structure in the coding genes. The expansion of successful resistant clones varies among the different regions and is influenced by the use of antibiotics, vaccines, particularly conjugated ones, as well as population density. Parenteral treatment with high doses of penicillin G continues to be effective for the treatment of pneumonia and bacteremia, oral aminopenicillins for otitis media and sinusitis and third generation cephalosporins for meningitis. Streptococcus pneumoniae es un importante agente causal de neumonía, meningitis, sepsis, bacteriemia y otitis media. En la Argentina, las tasas de resistencia a penicilina en Streptococcus pneumoniae se mantuvieron estables durante los últimos años. Hacia finales de los años noventa, un mayor número de aislamientos presentaban CIM de penicilina ≥2 μg/ml, pero su frecuencia disminuyó en los últimos años. La expresión fenotípica de resistencia a penicilina se debe a una modificación en las proteínas de unión a la penicilina, asociada a una estructura en mosaico en los genes codificantes. La expansión de clones resistentes exitosos varía entre diferentes regiones y está influida por el uso de antibióticos y de vacunas, particularmente de las conjugadas, así como por la densidad de la población. El tratamiento por vía parenteral con altas dosis de penicilina G continúa siendo eficaz para el tratamiento de las neumonías y bacteriemias, con aminopenicilinas por vía oral para otitis media y sinusitis, y con cefalosporinas de tercera generación para meningitis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0325754121000419; http://dx.doi.org/10.1016/j.ram.2021.02.007; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85104280004&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33875295; https://linkinghub.elsevier.com/retrieve/pii/S0325754121000419; https://dx.doi.org/10.1016/j.ram.2021.02.007
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know